🇩🇪 Bevacizumab in Germany

BfArM authorised Bevacizumab on 1 December 2005

Marketing authorisation

BfArM — authorised 1 December 2005

  • Marketing authorisation holder: Roche Registration Limited
  • Status: approved

Bevacizumab in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Germany

Frequently asked questions

Is Bevacizumab approved in Germany?

Yes. BfArM authorised it on 1 December 2005.

Who is the marketing authorisation holder for Bevacizumab in Germany?

Roche Registration Limited holds the German marketing authorisation.